Novel treatment options for Waldenström macroglobulinemia

about

Waldenström's macroglobulinemia: a clinical perspective in the era of novel therapeutics Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.Current treatment options and investigational drugs for Waldenstrom's Macroglobulinemia.

P2860

Q26776391-2A2AC941-6D65-4312-A11F-171AD5AAB906 Q38551391-2AA3FE7C-7C63-4406-B05E-B93D2A2455C1 Q39044362-15CE32F0-A025-4A29-A336-4816D9A2E0F6

P2860

Novel treatment options for Waldenström macroglobulinemia

Item

http://www.wikidata.org/entity/Q38167433

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel treatment options for Waldenström macroglobulinemia

@en

type

Item

label

Novel treatment options for Waldenström macroglobulinemia

@en

prefLabel

Novel treatment options for Waldenström macroglobulinemia

@en

P1476

Novel treatment options for Waldenström macroglobulinemia

@en

P2093

Amit Agarwal

http://www.w3.org/2001/XMLSchema#string

Houry Leblebjian

http://www.w3.org/2001/XMLSchema#string

Irene Ghobrial

http://www.w3.org/2001/XMLSchema#string

P2860

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

Waldenström macroglobulinemia

Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Diagnosis and management of Waldenstrom's macroglobulinemia

Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia

Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

How I treat Waldenström macroglobulinemia

Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells

Src tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom macroglobulinemia

P304

S310-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLML.2013.05.023

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

13 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24290218

http://www.w3.org/2001/XMLSchema#string

P932

3870149

http://www.w3.org/2001/XMLSchema#string

Novel treatment options for Waldenström macroglobulinemia

about

P2860

P2860

Novel treatment options for Waldenström macroglobulinemia

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932